SSY GROUP's two products received production registration approval from the National Medical Products Administration
SSY GROUP (02005.HK) announced that Sodium Lactate Ringer's Injection (3000ml) and Buprenorphine Injection (2ml:1mg) have obtained the drug production registration approval from the National Medical Products Administration of China, both classified as Category 3 chemical drugs, equivalent to passing the consistency evaluation
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments